A detailed history of Scs Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Scs Capital Management LLC holds 24,578 shares of ABBV stock, worth $5.81 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
24,578
Previous 17,600 39.65%
Holding current value
$5.81 Million
Previous $3.69 Million 23.73%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$170.16 - $206.27 $1.19 Million - $1.44 Million
6,978 Added 39.65%
24,578 $4.56 Million
Q1 2025

May 14, 2025

BUY
$169.2 - $216.66 $2.98 Million - $3.81 Million
17,600 New
17,600 $3.69 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $418B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Scs Capital Management LLC Portfolio

Follow Scs Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scs Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scs Capital Management LLC with notifications on news.